News Releases Year None2020201920182017 Feb 18, 2020 ALX Oncology’s ALX148 Receives Two Fast Track Designations from FDA for the Treatment of Patients with Head and Neck Squamous Cell Carcinoma and Patients with Gastric or Gastroesophageal Junction Adenocarcinoma Read more Feb 12, 2020 ALX Oncology Announces Closing of $105 Million Series C Financing Read more Jan 7, 2020 ALX Oncology Appoints Peter S. García as Chief Financial Officer Read more Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 13 of 13
